Keywords: ImClone, Waksal, Kadmon, Financing

ImClone founder Sam Waksal trying to raise $50 million to back new biotech venture

Article | 17 February 2010

Samuel Waksal, the former chief executive of US biotechnology firm ImClone Systems, who due to an insider trading scandal led ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in